Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

946
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
946
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

9.4K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.4K
Neurotransmitters01:31

Neurotransmitters

1.6K
Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
1.6K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

33
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
33
Introduction to Hemostasis01:05

Introduction to Hemostasis

9.1K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
9.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence for Multiple Binding Modes in the Initial Contact Between SARS-CoV-2 Spike S1 Protein and Cell Surface Glycans.

Chemistry (Weinheim an der Bergstrasse, Germany)·2022
Same author

NMR Reveals Functionally Relevant Thermally Induced Structural Changes within the Native Ensemble of G-CSF.

Molecular pharmaceutics·2022
Same author

Using NMR to Dissect the Chemical Space and <i>O</i>-Sulfation Effects within the <i>O</i>- and <i>S</i>-Glycoside Analogues of Heparan Sulfate.

ACS omega·2022
Same author

Evaluation of Critical Quality Attributes of a Pentavalent (A, C, Y, W, X) Meningococcal Conjugate Vaccine for Global Use.

Pathogens (Basel, Switzerland)·2021
Same author

NMR observation of HIV-1 gp120 conformational flexibility resulting from V3 truncation.

The FEBS journal·2014
Same author

NMR mapping of RANTES surfaces interacting with CCR5 using linked extracellular domains.

The FEBS journal·2013

Related Experiment Video

Updated: Sep 24, 2025

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

13.9K

The interaction between oxytocin and heparin.

Einat Schnur1, Timothy R Rudd1

  • 1National Institute of Biological Standards and Control Blanche Lane, South Mimms Potters Bar Hertfordshire EN6 3QG UK einat.schnur@nibsc.org tim.rudd@nibsc.org.

RSC Advances
|May 6, 2022
PubMed
Summary

Oxytocin (OXT) and heparin oligosaccharides interact, with sulfation crucial for binding. This research reveals key molecular interactions influencing OXT

More Related Videos

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
12:27

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery

Published on: August 22, 2016

7.7K
A Novel In vitro Model for Studying the Interactions Between Human Whole Blood and Endothelium
06:27

A Novel In vitro Model for Studying the Interactions Between Human Whole Blood and Endothelium

Published on: November 21, 2014

9.6K

Related Experiment Videos

Last Updated: Sep 24, 2025

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

13.9K
Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
12:27

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery

Published on: August 22, 2016

7.7K
A Novel In vitro Model for Studying the Interactions Between Human Whole Blood and Endothelium
06:27

A Novel In vitro Model for Studying the Interactions Between Human Whole Blood and Endothelium

Published on: November 21, 2014

9.6K

Area of Science:

  • Biochemistry
  • Carbohydrate Chemistry
  • Pharmacology

Background:

  • Oxytocin (OXT) is used to induce labor.
  • Low molecular weight heparin (dalteparin) may accelerate OXT-induced labor.
  • Heparin oligosaccharides share structural similarities with dalteparin.

Purpose of the Study:

  • To investigate the molecular interactions between oxytocin and various heparin-based oligosaccharides.
  • To identify the specific structural features of heparin important for OXT binding.
  • To understand the role of sulfation in OXT-oligosaccharide complex formation.

Main Methods:

  • Nuclear Magnetic Resonance (NMR) spectroscopy (¹³C-¹H and ¹⁵N-¹H HSQC) was used to study interactions.
  • Experiments were conducted at a range of temperatures to analyze binding.
  • Chemically derived heparin hexasaccharides were synthesized and utilized.

Main Results:

  • Specific binding epitopes between OXT and heparin oligosaccharides were identified.
  • Heparin's 6-O-sulfation and N-sulfation were found to be critical for OXT interaction.
  • Hydrogen bonding plays a significant role in the OXT-fondaparinux complex.

Conclusions:

  • Heparin's sulfation patterns significantly influence its interaction with oxytocin.
  • Understanding these interactions could inform the development of OXT-based therapies.
  • The findings provide molecular insights into heparin's potential to modulate OXT efficacy.